1 Kang I Park SH . Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol2003; 15: 528–534.
2.
2 Kahl LE . Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol1994; 21: 84–86.
3.
3 Hu W Liu Z Chen H . Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Chin Med J (Engl)2002; 115: 705–709.
4.
4 Ginzler EM Dooley MA Aranow C . Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med2005; 353: 2219–2228.